Cargando…

Increased PARP Activity and DNA Damage in NSCLC Patients: The Influence of COPD

SIMPLE SUMMARY: Many people still die of lung cancer (LC), a disease that is mainly related to cigarette smoking. Smokers may also develop chronic obstructive pulmonary disease (COPD). COPD is a risk factor per se for LC. Cigarette smoking and other chemicals injure DNA on a daily basis. A repair me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Jun, Curull, Víctor, Wang, Xuejie, Ampurdanés, Coral, Duran, Xavier, Pijuan, Lara, Rodríguez-Fuster, Alberto, Aguiló, Rafael, Yélamos, José, Barreiro, Esther
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697659/ https://www.ncbi.nlm.nih.gov/pubmed/33187221 http://dx.doi.org/10.3390/cancers12113333

Ejemplares similares

Immune Cell Subtypes and Cytokines in Lung Tumor Microenvironment: Influence of COPD
por: Tang, Jun, et al.
Publicado: (2020)

B Cells and Tertiary Lymphoid Structures Influence Survival in Lung Cancer Patients with Resectable Tumors
por: Tang, Jun, et al.
Publicado: (2020)

Attenuation of Tumor Burden in Response to Rucaparib in Lung Adenocarcinoma: The Contribution of Oxidative Stress, Apoptosis, and DNA Damage
por: Pérez-Peiró, Maria, et al.
Publicado: (2023)

Profile of epigenetic mechanisms in lung tumors of patients with underlying chronic respiratory conditions
por: Mateu-Jimenez, Mercè, et al.
Publicado: (2018)

Gene expression profile of epithelial–mesenchymal transition in tumours of patients with nonsmall cell lung cancer: the influence of COPD
por: Xia, Yingchen, et al.
Publicado: (2022)

Attenuation of Muscle Damage, Structural Abnormalities, and Physical Activity in Respiratory and Limb Muscles following Treatment with Rucaparib in Lung Cancer Cachexia Mice
por: Pérez-Peiró, Maria, et al.
Publicado: (2022)

PARP-1/PARP-2 double deficiency in mouse T cells results in faulty immune responses and T lymphomas
por: Navarro, Judith, et al.
Publicado: (2017)

Systemic Profiles of microRNAs, Redox Balance, and Inflammation in Lung Cancer Patients: Influence of COPD
por: Qin, Liyun, et al.
Publicado: (2021)

Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies
por: Yélamos, José, et al.
Publicado: (2020)

A foreign body reaction to Surgicel(®) in a lymph node diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration
por: Badenes, Diana, et al.
Publicado: (2017)

Epigenetic Mechanisms in Respiratory Muscle Dysfunction of Patients with Chronic Obstructive Pulmonary Disease
por: Puig-Vilanova, Ester, et al.
Publicado: (2014)

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
por: van Beek, Lotte, et al.
Publicado: (2021)

PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites
por: Lin, Xiaohui, et al.
Publicado: (2022)

Iron Depletion in Systemic and Muscle Compartments Defines a Specific Phenotype of Severe COPD in Female and Male Patients: Implications in Exercise Tolerance
por: Pérez-Peiró, Maria, et al.
Publicado: (2022)

Lights and shadows of non-invasive mechanical ventilation for chronic obstructive pulmonary disease (COPD) exacerbations
por: Lopez-Campos, Jose Luis, et al.
Publicado: (2015)

Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo
por: Shao, Zhengping, et al.
Publicado: (2020)

Iron Replacement and Redox Balance in Non-Anemic and Mildly Anemic Iron Deficiency COPD Patients: Insights from a Clinical Trial
por: Pérez-Peiró, Maria, et al.
Publicado: (2021)

PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response
por: Kim, Chiho, et al.
Publicado: (2020)

PARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis?
por: Swindall, Amanda F., et al.
Publicado: (2013)

Interaction between ATM and PARP-1 in response to DNA damage and sensitization of ATM deficient cells through PARP inhibition
por: Aguilar-Quesada, Rocío, et al.
Publicado: (2007)

Dynamics of endogenous PARP1 and PARP2 during DNA damage revealed by live-cell single-molecule imaging
por: Mahadevan, Jyothi, et al.
Publicado: (2022)

New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage
por: Gu, Zongying, et al.
Publicado: (2019)

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)
por: Casadevall, David, et al.
Publicado: (2015)

EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma
por: Chalela, Roberto, et al.
Publicado: (2019)

DNA damage induced by KP372-1 hyperactivates PARP1 and enhances lethality of pancreatic cancer cells with PARP inhibition
por: Viera, Talysa, et al.
Publicado: (2020)

PARP-2 domain requirements for DNA damage-dependent activation and localization to sites of DNA damage
por: Riccio, Amanda A., et al.
Publicado: (2016)

Inhibition of DNA damage repair by artificial activation of PARP with siDNA
por: Croset, Amelie, et al.
Publicado: (2013)

PARP-1 Modulates Amyloid Beta Peptide-Induced Neuronal Damage
por: Martire, Sara, et al.
Publicado: (2013)

SIRT1/PARP1 crosstalk: connecting DNA damage and metabolism
por: Luna, Augustin, et al.
Publicado: (2013)

Characterization of the interactions of PARP-1 with UV-damaged DNA in vivo and in vitro
por: Purohit, Nupur K., et al.
Publicado: (2016)

Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response
por: Francica, Paola, et al.
Publicado: (2018)

NADP(+) is an endogenous PARP inhibitor in DNA damage response and tumor suppression
por: Bian, Chunjing, et al.
Publicado: (2019)

PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures
por: McNevin, Ciara S., et al.
Publicado: (2022)

PEM Electrolysis‐Assisted Catalysis Combined with Photocatalytic Oxidation towards Complete Abatement of Nitrogen‐Containing Contaminants in Water
por: Ampurdanés, Jordi, et al.
Publicado: (2021)

Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry
por: Isabelle, Maxim, et al.
Publicado: (2010)

Impact of DNA Damage Response—Targeted Therapies on the Immune Response to Tumours
por: Lutfi, Nura, et al.
Publicado: (2021)

Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer
por: Gout, Johann, et al.
Publicado: (2021)

Single cell resolution in vivo imaging of DNA damage following PARP inhibition
por: Yang, Katherine S., et al.
Publicado: (2015)

Strategic Combination of DNA-Damaging Agent and PARP Inhibitor Results in Enhanced Cytotoxicity
por: Horton, Julie K., et al.
Publicado: (2013)

PARP2 mediates branched poly ADP-ribosylation in response to DNA damage
por: Chen, Qian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_828eug4ge8fpcf54f68ppu5eoe